A detailed history of Voloridge Investment Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 215,731 shares of HROW stock, worth $7.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
215,731
Holding current value
$7.9 Million
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.85 - $46.47 $4.5 Million - $10 Million
215,731 New
215,731 $9.7 Million
Q3 2023

Nov 14, 2023

SELL
$14.03 - $22.08 $82,510 - $129,852
-5,881 Reduced 7.84%
69,152 $993,000
Q2 2023

Aug 14, 2023

BUY
$17.37 - $28.08 $1.3 Million - $2.11 Million
75,033 New
75,033 $1.43 Million

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $992M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.